Targeting Heat Shock Proteins in Cancer: A Promising Therapeutic ApproachSuman Chatterjee, Timothy F. Burns|International Journal of Molecular Sciences|2017Cited by 505
Identification of Inhibitors of TRAIL-induced Death (ITIDs) in the TRAIL-sensitive Colon Carcinoma Cell Line SW480 Using a Genetic ApproachTimothy F. Burns, Wafik S. El‐Deiry|Journal of Biological Chemistry|2001Cited by 155
Abstract CT028: A first-in-human phase 1 study of LY3537982, a highly selective and potent KRAS G12C inhibitor in patients with KRAS G12C-mutant advanced solid tumorsYonina R. Murciano‐Goroff, Joshua K. Sabari, Yasutoshi Kuboki et al.|Cancer Research|2023Cited by 37